skip to Main Content
  • This page as PDF

Avalere Broadens Market Access Capabilities with 3 New Hires

Summary

Each brings leadership and deep experience within the life sciences industry.

Avalere’s Market Access practice recently hired 3 new associate principals: Lilian Buch, David Kowalsky, and Saran Traore. They will work with a variety of life sciences clients on issues tied to access, patient support programs, and reimbursement.

“The combined effect of major health insurance coverage shifts and the growing influence of the patient voice presents significant challenges and opportunities for life sciences companies,” said Lance Grady, Practice Director at Avalere Health. “Lilian, David, and Saran each bring unique experiences to Avalere, ranging in therapeutic areas and functional expertise. We are thrilled to have them at the firm.”

About Lilian Buch

Lilian comes to Avalere from Bristol-Meyers Squibb. She most recently was a senior access and reimbursement manager. During Lilian’s time with the company, she supported and executed patient-access program strategies for oncology, rheumatology, and transplant portfolios. Lilian held similar roles at Savient Pharmaceuticals, Biogen Idec, Abbott Laboratories, and Aventis Pharmaceuticals. She has also successfully launched orphan, immuno-oncology, and autoimmune drugs, and has expertise in commercial payer medical policy and utilization management, Medicare payment models, and impact of healthcare policy on patient access.

“I’m excited to join Avalere’s growing Market Access team,” said Lilian Buch, Associate Principal at Avalere. “I look forward to partnering with manufacturers in developing solutions related to coverage, coding, and payment.”

Lilian holds a BA from the University of Northern Iowa and is certified as a professional biller by the American Academy of Professional Coders.

About David Kowalsky

David comes to Avalere from Eyepoint Pharmaceuticals, where he was a director of Patient Access, Reimbursement, and Market Access. In this role, he developed the patient-access strategy and programs for 2 product launches. David also built a field reimbursement team and led the implementation of a new hub vendor. He previously worked at Novo Nordisk and held roles in patient access, market access execution, finance, and strategic pricing.

“This is an exciting time to join Avalere’s Market Access team,” said David Kowalsky, Associate Principal at Avalere. “We are at such an important juncture in healthcare, and Avalere’s robust data set provides stakeholders with the information they need to make well-informed decisions.”

David holds an MBA from Rutgers Business School and a BA from the University of Pittsburgh. David is currently a lieutenant colonel in the New Jersey Air National Guard.

About Saran Traore

She comes to Avalere from AstraZeneca. She most recently served as a strategic alignment leader for the Field Reimbursement Team for Market Access. In this role, she was responsible for optimizing the team’s strategic and operational effectiveness. She previously worked at The Johns Hopkins Hospital as a clinical customer service coordinator, focused on improving patient experience.

“I look forward to working with Avalere’s broad set of life sciences clients on their most pressing patient access issues,” said Saran Traore, Associate Principal at Avalere. “Avalere’s ability to quantify and translate what policy and marketplace developments might mean for manufacturers is unmatched.”

She holds an MS from the University of Maryland University College and a BA from Towson University.

To receive Avalere updates, connect with us.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top